Cargando…
Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice
SIMPLE SUMMARY: The transfer of a normal intestinal microbial community from healthy donors by way of their fecal material into patients with various diseases is an emerging therapeutic approach, particularly to treat patients with recurrent or refractory C. difficile infections (CDI). This approach...
Autores principales: | Bou Zerdan, Maroun, Niforatos, Stephanie, Nasr, Sandy, Nasr, Dayana, Ombada, Mulham, John, Savio, Dutta, Dibyendu, Lim, Seah H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833574/ https://www.ncbi.nlm.nih.gov/pubmed/35158960 http://dx.doi.org/10.3390/cancers14030691 |
Ejemplares similares
-
Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation
por: Nasr, Dayana, et al.
Publicado: (2022) -
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer
por: Bou Zerdan, Maroun, et al.
Publicado: (2023) -
The Lung Microbiota and Lung Cancer: A Growing Relationship
por: Bou Zerdan, Maroun, et al.
Publicado: (2022) -
A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022) -
Intestinal barrier functions in hematologic and oncologic diseases
por: Haroun, Elio, et al.
Publicado: (2023)